Requests that the FDA initiate all administrative and judicial action necessary to remove from the market, and to prevent the further marketing of lidocaine-containing drug products in patch, plaster, poultice, or comparable delivery systems that have not been approved pursuant to a new drug application or an abbreviated new drug application submitted under 21 U.S.C. § 355 and implementing

1 organizations filed 1 public comment on Requests that the FDA initiate all administrative and judicial action necessary to remove from the market, and to prevent the further marketing of lidocaine-containing drug products in patch, plaster, poultice, or comparable delivery systems that have not been approved pursuant to a new drug application or an abbreviated new drug application submitted under 21 U.S.C. § 355 and implementing, at the Food and Drug Administration. The comment window closed 2556d ago.

Abstract

CLOSED

Commenters (1)

• Consumer Healthcare Products Associationtrade assoc.

  1 filing · confidence 97%